Alumis Inc. (NASDAQ: ALMS), a burgeoning name in the biotechnology sector, is drawing attention from investors with its promising pipeline and potential for substantial upside. This clinical-stage biopharmaceutical company is..
Alpha Teknova, Inc. (NASDAQ: TKNO) is making waves in the healthcare sector with its innovative approach to supplying critical reagents essential for the development of novel therapies and diagnostics. The..
A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology company traded on an undisclosed exchange, is making waves in the Software – Application industry with its innovative retail automation solutions. With..
Investors seeking opportunities in the biotechnology sector may find aTyr Pharma, Inc. (NASDAQ: ATYR) an intriguing candidate, particularly given its notable potential upside of 456.40%. As a clinical-stage biotechnology company,..
Aura Biosciences, Inc. (NASDAQ: AURA) presents an intriguing opportunity for investors in the dynamic biotechnology sector. The company, headquartered in Boston, Massachusetts, specializes in developing precision therapies for solid tumors...
SoundHound AI, Inc. (NASDAQ: SOUN) has emerged as a noteworthy player within the technology sector, specializing in the development of independent voice AI solutions. With a market capitalization of $4.19..
Phathom Pharmaceuticals, Inc. (PHAT), a rising player in the biotechnology sector, is capturing investor attention with its promising focus on gastrointestinal treatments. The company’s market capitalization stands at $1.18 billion,..
Quhuo Limited – American Depositary Shares (QH), a player in the technology sector, operates a comprehensive gig economy platform for life services in China. Despite its innovative approach to on-demand..
Erasca, Inc. (NASDAQ: ERAS) has garnered significant attention from investors with its focus on precision oncology and its promising pipeline of therapies targeting RAS/MAPK pathway-driven cancers. As a clinical-stage biotechnology..
Quantum-Si Incorporated (NASDAQ: QSI), a trailblazer in the healthcare sector, specifically within the medical devices industry, has been drawing attention with its pioneering work in Next Generation Protein Sequencing (NGPS)...
Outset Medical, Inc. (NASDAQ: OM) is an intriguing player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $67.35 million, Outset Medical focuses on..
Neuronetics, Inc. (NASDAQ: STIM), a prominent player in the healthcare sector, specifically within the medical devices industry, is garnering significant attention from investors due to its compelling potential upside of..
Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, has captured the interest of investors with its pioneering work in immunotherapy, specifically targeting the Lymphocyte Activation Gene-3 (LAG-3) pathway. As the..
Spok Holdings, Inc. (NASDAQ: SPOK) is capturing investor attention with its compelling dividend yield and significant upside potential. Operating within the healthcare sector, specifically in health information services, Spok Holdings..
Cytek Biosciences, Inc. (NASDAQ: CTKB), a prominent player in the healthcare sector focusing on medical devices, offers a compelling case for investors interested in the intersection of technology and biotechnology...
National Research Corporation (NRC), a prominent player in the healthcare industry, specializes in health information services. Despite its relatively modest market cap of $432.9 million, this U.S.-based company is making..
Entrada Therapeutics, Inc. (NASDAQ: TRDA) is capturing the attention of investors with its innovative approach to developing therapies that target previously inaccessible intracellular areas. As a clinical-stage biopharmaceutical company, Entrada..
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a prominent player in the biotechnology sector, is currently capturing investor attention with its promising potential upside of 479.12%. With a market capitalization of..
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), a clinical-stage biopharmaceutical company based in San Francisco, is capturing the attention of investors with its promising pipeline focused on women’s cancers. Specializing in the..
